Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1992 1
1993 1
1994 2
1995 1
1996 2
1997 1
1998 1
1999 1
2001 1
2003 1
2006 3
2007 3
2008 5
2009 6
2010 6
2011 2
2012 9
2013 8
2014 4
2015 4
2016 6
2017 6
2018 5
2019 4
2020 8
2021 4
2022 4
2023 11
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

103 results

Results by year

Filters applied: . Clear all
Page 1
Imlifidase, a new option to optimize the management of patients with hemophilia A on emicizumab.
Bou-Jaoudeh M, Mimoun A, Delignat S, Peyron I, Capdevila L, Daventure V, Deligne C, Dimitrov JD, Christophe OD, Denis CV, Lenting PJ, Proulle V, Lacroix-Desmazes S. Bou-Jaoudeh M, et al. Among authors: christophe od. J Thromb Haemost. 2023 Oct;21(10):2776-2783. doi: 10.1016/j.jtha.2023.06.038. Epub 2023 Jul 18. J Thromb Haemost. 2023. PMID: 37473843 Free article.
Clearance of von Willebrand factor.
Casari C, Lenting PJ, Wohner N, Christophe OD, Denis CV. Casari C, et al. Among authors: christophe od. J Thromb Haemost. 2013 Jun;11 Suppl 1:202-11. doi: 10.1111/jth.12226. J Thromb Haemost. 2013. PMID: 23809124 Free article. Review.
Emerging Therapeutic Strategies in the Treatment of Hemophilia A.
Muczynski V, Christophe OD, Denis CV, Lenting PJ. Muczynski V, et al. Among authors: christophe od. Semin Thromb Hemost. 2017 Sep;43(6):581-590. doi: 10.1055/s-0037-1604053. Epub 2017 Jul 27. Semin Thromb Hemost. 2017. PMID: 28750425 Review. No abstract available.
Transplacental delivery of therapeutic proteins by engineered immunoglobulin G: a step toward perinatal replacement therapy.
Mimoun A, Bou-Jaoudeh M, Delignat S, Daventure V, Reyes Ruiz A, Lecerf M, Azam A, Noe R, Peyron I, Christophe OD, Lenting PJ, Proulle V, McIntosh J, Nathwani AC, Dimitrov JD, Denis CV, Lacroix-Desmazes S. Mimoun A, et al. Among authors: christophe od. J Thromb Haemost. 2023 Sep;21(9):2405-2417. doi: 10.1016/j.jtha.2023.05.021. Epub 2023 Jun 2. J Thromb Haemost. 2023. PMID: 37271431
The disappearing act of factor VIII.
Lenting PJ, Christophe OD, Guéguen P. Lenting PJ, et al. Among authors: christophe od. Haemophilia. 2010 May;16(102):6-15. doi: 10.1111/j.1365-2516.2008.01864.x. Epub 2008 Sep 1. Haemophilia. 2010. PMID: 18771423 Review.
Clearance of von Willebrand factor.
Denis CV, Christophe OD, Oortwijn BD, Lenting PJ. Denis CV, et al. Among authors: christophe od. Thromb Haemost. 2008 Feb;99(2):271-8. doi: 10.1160/TH07-10-0629. Thromb Haemost. 2008. PMID: 18278174 Review.
A nanobody against the VWF A3 domain detects ADAMTS13-induced proteolysis in congenital and acquired VWD.
Kizlik-Masson C, Peyron I, Gangnard S, Le Goff G, Lenoir SM, Damodaran S, Clavel M, Roullet S, Regnault V, Rauch A, Vincent F, Jeanpierre E, Dupont A, Ternisien C, Donnet T, Christophe OD, van Belle E, Denis CV, Casari C, Susen S, Lenting PJ. Kizlik-Masson C, et al. Among authors: christophe od. Blood. 2023 Mar 23;141(12):1457-1468. doi: 10.1182/blood.2022017569. Blood. 2023. PMID: 36564031 Free article.
103 results